Prevention of Asthma Relapse After Discharge From Emergency

AstraZeneca600 enrolled

Overview

The purpose of this study is to compare the Symbicort® Turbuhaler® to both Pulmicort® Turbuhaler® and Bricanyl® Turbuhaler® for the treatment of asthma after discharge from the emergency room

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

600

Conditions

Asthma

Interventions

Budesonide/formoterolDRUG

Eligibility

Sex: ALLMin age: 18 YearsMax age: 65 Years

Medical Language ↔ Plain English

Inclusion Criteria: * 18 - 65 years of age * Presenting at a study emergency department with an asthma exacerbation Exclusion Criteria: * Admission to hospital * Patients receiving more than 2000 µg/day of beclomethasone equivalent inhaled corticosteroids (1000 µg/day fluticasone or 1600 µg/day budesonide)

Locations (20)

Research Site

Calgary, Alberta, Canada

Research Site

Edmonton, Alberta, Canada

Outcomes

Primary Outcomes

Time to first asthma relapse

Secondary Outcomes

Mean use of reliever medication

Asthma Control Questionnaire (ACQ) score

Complete AE and SAE collection

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.